Building Resilience into the Nation's Medical Product Supply Chains

個数:

Building Resilience into the Nation's Medical Product Supply Chains

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 364 p.
  • 言語 ENG
  • 商品コード 9780309274692

Full Description

Over the past several decades, supply chain disruptions have repeatedly plagued the U.S. health care system, costing health care systems millions of dollars per year, threatening the clinical research enterprise, and most importantly, imperiling the health and lives of patients. The Committee on Security of America's Medical Supply Chain, convened by the National Academies of Sciences, Engineering, and Medicine, was charged with addressing this important issue by examining the root causes of medical product shortages and identifying ways to enhance their resilience - both in so-called normal times and during public health emergencies.

Building Resilience into the Nation's Medical Product Supply Chains outlines the committee's seven recommendations and presents a framework of protection comprising awareness, mitigation, preparedness, and response measures.

Table of Contents

Front Matter
Summary
PART I: OVERVIEW OF GLOBAL MEDICAL PRODUCT SUPPLY CHAINS
1 Introduction
2 Understanding Medical Product Supply Chains
3 Globalization of U.S. Medical Product Supply Chains
4 Causes and Consequences of Medical Product Supply Chain Failures
PART II: MEASURES FOR ENHANCING THE RESILIENCY OF MEDICAL PRODUCT SUPPLY CHAINS
5 A Framework for Resilient Medical Product Supply Chains
6 Awareness Measures for Resilient Medical Product Supply Chains
7 Mitigation Measures for Resilient Medical Product Supply Chains
8 Preparedness Measures for Resilient Medical Product Supply Chains
9 Response Measures for Resilient Medical Product Supply Chains
Appendix A: Study Methods and Public Agendas
Appendix B: Summary of Recommendations from Contemporary Reports
Appendix C: Determining Risk Values When Evaluating Medical Product Supply Chain Resilience
Appendix D: Commissioned Economic Analysis
Appendix E: Committee and Staff Biosketches
Appendix F: Disclosure of Unavoidable Conflict of Interest

最近チェックした商品